NCT05069389

Brief Summary

The purpose of the study is to describe medical care strategies implemented by healthcare establishments for patients affected by COVID-19

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,071

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 2, 2020

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

September 30, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 6, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

July 8, 2024

Status Verified

July 1, 2024

Enrollment Period

3.6 years

First QC Date

September 30, 2021

Last Update Submit

July 5, 2024

Conditions

COVID-19 Infection

Keywords

COVID-19medical care strategieshospitalisation

Outcome Measures

Primary Outcomes (1)

  • Describe management strategies implemented by healthcare establishments for patients with covid-19, depending on the evolution of scientific knowledge and recommendations for specific treatments.

    The use of specific treatments or specific care in COVID unit, inclusion in clinical trials, will be combined to report the evolution of French recommendations and scientific literature around the COVID-19.

    During the hospitalization

Secondary Outcomes (4)

  • Describe management strategies to take care depending on the patient

    During the hospitalization

  • Compare patients' clinical course who received different management strategies

    During the hospitalization

  • Evaluate the cost of the care

    During the hospitalization

  • Evaluate the effectiveness of the care

    During the hospitalization

Interventions

Data collectionOTHER

Some data will be collected for all patients included : * specific treatment administered in COVID unit * dosages of treatment * inclusion in clinical trials Evolution of French recommendations and the publication of scientific articles

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient diagnosed for COVID-19 infection and hospitalized in healthcare establishment in 2020

You may qualify if:

  • Any adult patient admitted to the establishment for treatment for a SARS-Cov2 infection
  • Positive RT-PCR or a scanner suggestive of COVID-19 during the stay, or with a positive serology (even if carried out after the patient's discharge)
  • Hospitalization \> 24h
  • Patients receiving any type of care, whether it is recommended standard care or off-label treatment as part of a therapeutic clinical trial or outside the scope of clinical research

You may not qualify if:

  • Opposition to the use of data following written patient information
  • Patient transferred from another hospital to continue COVID care and whose initial care data is not available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Center Emile Roux

Le Puy-en-Velay, 43012, France

Location

MeSH Terms

Conditions

COVID-19

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 30, 2021

First Posted

October 6, 2021

Study Start

June 2, 2020

Primary Completion

December 31, 2023

Study Completion

July 31, 2025

Last Updated

July 8, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)